Please login to the form below

Not currently logged in
Email:
Password:

Generic Pharmaceutical Association

This page shows the latest Generic Pharmaceutical Association news and features for those working in and with pharma, biotech and healthcare.

Novartis weighs in on biosimilar naming debate

Novartis weighs in on biosimilar naming debate

The views of the ASBM have been challenged by the likes of the Generic Pharmaceutical Association (GPhA) who want to keep the current system of biosimilar naming, claiming there is no ... Now Novartis, which has a 50 per cent share of all biosimilars

Latest news

  • Generics industry pressures FDA over biosimilar naming standards Generics industry pressures FDA over biosimilar naming standards

    Trade body the Generic Pharmaceutical Association (GPhA) has filed a Citizen Petition with the Food and Drug Administration (FDA) which claims that there is no clinically meaningful difference between a branded ... For standard generic medicines –

  • Mylan’s president Tony Mauro elected chair of GPhA

    Tony Mauro, president of Mylan Pharmaceuticals, has been elected as the new chair of the US-based Generic Pharmaceutical Association (GPhA). ... The generic pharmaceutical industry, which accounts for 78 per cent of all prescriptions dispensed in the US,

  • FDA takes action on US cancer drug shortages

    The FDA also approved Illinois-based APP Pharmaceuticals to supply generic preservative-free methotrexate, which is used as chemotherapy in several cancers. ... The news was welcomed by the US Generic Pharmaceutical Association (GPhA), which said

  • FDA unveils user-fee schemes for generics and biosimilars

    the Generic Pharmaceutical Association (GPhA). ... The generic drug fees alone could raise in the region of $300m a year over the next five years.

  • US generics group's drug shortage plea

    US generics group's drug shortage plea. The US Generic Pharmaceutical Association (GPhA) has blamed intensified regulation for drug shortages in the US and called for greater collaboration between stakeholders to ... The record number of drug shortages

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics